| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| A2M | C6 | ENSSSCP00000000701 | ENSSSCP00000070538 | Alpha-2-macroglobulin. | Uncharacterized protein. | 0.501 |
| A2M | C7 | ENSSSCP00000000701 | ENSSSCP00000017865 | Alpha-2-macroglobulin. | Complement component C7; Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor. Belongs to the complement C6/C7/C8/C9 family. | 0.601 |
| A2M | C8A | ENSSSCP00000000701 | ENSSSCP00000004152 | Alpha-2-macroglobulin. | Complement C8 alpha chain. | 0.487 |
| A2M | C8G | ENSSSCP00000000701 | ENSSSCP00000042850 | Alpha-2-macroglobulin. | Complement C8 gamma chain. | 0.600 |
| A2M | C9 | ENSSSCP00000000701 | ENSSSCP00000017860 | Alpha-2-macroglobulin. | MACPF domain-containing protein. | 0.569 |
| A2M | CFI | ENSSSCP00000000701 | ENSSSCP00000046137 | Alpha-2-macroglobulin. | Complement factor I isoform 1 preproprotein; Belongs to the peptidase S1 family. | 0.485 |
| A2M | CLU | ENSSSCP00000000701 | ENSSSCP00000052651 | Alpha-2-macroglobulin. | Clusterin alpha chain; Functions as extracellular chaperone that prevents aggregation of non native proteins. Prevents stress-induced aggregation of blood plasma proteins. Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro). Does not require ATP. Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC70. Does not refold proteins by itself. Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysos [...] | 0.739 |
| C5 | C6 | ENSSSCP00000043852 | ENSSSCP00000070538 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | Uncharacterized protein. | 0.999 |
| C5 | C7 | ENSSSCP00000043852 | ENSSSCP00000017865 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | Complement component C7; Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor. Belongs to the complement C6/C7/C8/C9 family. | 0.999 |
| C5 | C8A | ENSSSCP00000043852 | ENSSSCP00000004152 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | Complement C8 alpha chain. | 0.999 |
| C5 | C8B | ENSSSCP00000043852 | ENSSSCP00000047073 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | MACPF domain-containing protein. | 0.994 |
| C5 | C8G | ENSSSCP00000043852 | ENSSSCP00000042850 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | Complement C8 gamma chain. | 0.998 |
| C5 | C9 | ENSSSCP00000043852 | ENSSSCP00000017860 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | MACPF domain-containing protein. | 0.999 |
| C5 | CD59 | ENSSSCP00000043852 | ENSSSCP00000025898 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | CD59 glycoprotein; Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. | 0.571 |
| C5 | CFI | ENSSSCP00000043852 | ENSSSCP00000046137 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | Complement factor I isoform 1 preproprotein; Belongs to the peptidase S1 family. | 0.838 |
| C5 | CLU | ENSSSCP00000043852 | ENSSSCP00000052651 | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | Clusterin alpha chain; Functions as extracellular chaperone that prevents aggregation of non native proteins. Prevents stress-induced aggregation of blood plasma proteins. Inhibits formation of amyloid fibrils by APP, APOC2, B2M, CALCA, CSN3, SNCA and aggregation-prone LYZ variants (in vitro). Does not require ATP. Maintains partially unfolded proteins in a state appropriate for subsequent refolding by other chaperones, such as HSPA8/HSC70. Does not refold proteins by itself. Binding to cell surface receptors triggers internalization of the chaperone-client complex and subsequent lysos [...] | 0.554 |
| C6 | A2M | ENSSSCP00000070538 | ENSSSCP00000000701 | Uncharacterized protein. | Alpha-2-macroglobulin. | 0.501 |
| C6 | C5 | ENSSSCP00000070538 | ENSSSCP00000043852 | Uncharacterized protein. | Complement C5a anaphylatoxin; Derived from proteolytic degradation of complement C5, C5 anaphylatoxin is a mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes. C5a is also a potent chemokine which stimulates the locomotion of polymorphonuclear leukocytes and directs their migration toward sites of inflammation. | 0.999 |
| C6 | C7 | ENSSSCP00000070538 | ENSSSCP00000017865 | Uncharacterized protein. | Complement component C7; Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells. C7 serves as a membrane anchor. Belongs to the complement C6/C7/C8/C9 family. | 0.999 |
| C6 | C8A | ENSSSCP00000070538 | ENSSSCP00000004152 | Uncharacterized protein. | Complement C8 alpha chain. | 0.998 |